Look behind the lecture: AI and real-world evidence in cancer care

Written by The Evidence Base

In this interview, Jeff Elton (Concerto HealthAI, MA, USA) discusses his presentation from the American Society of Clinical Oncology (ASCO) annual meeting (31 May—4 June 2019; IL, USA) on the impact of artificial intelligence (AI) and real-world evidence on cancer care. Please introduce yourself and your institution. I am the CEO of Concerto HealthAI (MA, USA), a precision oncology company providing real-world evidence (RWE) solutions and technologies for life science companies, health providers and health payers. We believe the future of precision medicine, and precision oncology in particular, is the concept of ‘Precision Evidence’. Concerto HealthAI builds real-world data (RWD)...

To view this content, please register now for access

It's completely free